Kintor Pharma IPO: Valuation Insights
Kintor Pharmaceutical (9939 HK) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers and...
460 Views
Kintor Pharma IPO Initiation: To Screen, or Not to Screen?
Kintor Pharmaceutical (1762178D CH) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers...
400 Views
Akesobio: Trading Debut, Valuation Scenario Analysis
Akeso Biopharma Inc (9926 HK)Ā is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology, immunology...
600 Views
ECM Weekly (19 Apr 2020) - Kingsoft Cloud, Akesobio, Shenzhen Hepalink, China Gas, Yageo
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We are...
526 Views
ECM Weekly (22 Mar 2020) - ByteDance, Topsports, Budweiser, Innocare, Shanghai Henlius
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Even...
620 Views